Results 151 to 160 of about 13,364 (216)

Effectiveness and safety of anti-CGRP monoclonal antibodies in hemiplegic migraine: an individual patient quantitative analysis. [PDF]

J Headache Pain
Romozzi M, Palermo M, Danno D, Katsuki M, Tosto F, Signorelli F, Vollono C, Matsumori Y, Calabresi P, Ornello R, Iannone LF.   +10 more
europepmc   +1 more source

MIDAS: rapid, multiplexed molecular profiling for integrated host-pathogen analysis. [PDF]

Nat Commun
Lim YJ, Asadi Tokmedash M, Allen M, Gruich C, Choi JH, Kim C, Falkowski N, Goldsmith B, Stringer KA, Dickson RP, Bong KW, Min J.   +11 more
europepmc   +1 more source

Virtual reality-based assessment of visuo-vestibular integration in vestibular migraine and migraine: static and dynamic visual vertical and rod-and-frame tests. [PDF]

Front Neurol
Korkmaz H, Çıplak S, Alkahtani R.
europepmc   +1 more source

Results from TRIUMPH [EUROPE], a Real-World Observational Study on the 3-Month Effectiveness of Galcanezumab Versus Traditional Oral Migraine Preventive Medications. [PDF]

Pain Ther
Tassorelli C, Novick D, Gonderten S, Vincent M, Robinson RL, Martimianaki G, Pozo Rosich P.   +6 more
europepmc   +1 more source

Effect of Biological Therapy on Symptom Burden and Functional Disability in Patients with Migraine: A Before-and-After Analysis. [PDF]

Zdr Varst
Ličina A, Fabjan A, Žibert J, Kamenšek T.   +3 more
europepmc   +1 more source

State-specific disruptions of dynamic functional connectivity in young migraine without aura: a hidden Markov model approach. [PDF]

Front Neurosci
Xu C, Zhan S, Tan W, Cheng JM, Gong S, Lu S, Wang H, Liu F, Jiang S, Wang W, Yang Y.   +10 more
europepmc   +1 more source

Effect of Erenumab on Patient-Reported Outcomes in Episodic Migraine in Asia, the Middle East, and Latin America: Results From the EMPOwER Study. [PDF]

Neurol Clin Pract
Wang SJ, Roxas AA, Saravia B, Kim BK, Chowdhury D, Riachi NJ, Tai MS, Tanprawate S, Tran TN, Zhao YJ, Su W, Wen S, Mondal S, Ecochard L, Arkuszewski M.   +14 more
europepmc   +1 more source

Real-World Data on the Efficacy of OnabotulinumtoxinA Injections as Prophylactic Treatment for Migraine: A Retrospective Study from Jeddah, Saudi Arabia (2016-2024). [PDF]

Pain Ther
Attar A, Aladdin Y, Hakami A, Alqsair A, Baeisa S, Alzahrani A, Alsimsimi A, Alzebaidi S.   +7 more
europepmc   +1 more source

A Real-World Study of CGRP Monoclonal Antibodies for Migraine: Long-Term Effectiveness and Treatment Adherence. [PDF]

Eur J Neurol
Suzuki K, Suzuki S, Kobayashi S, Shioda M, Fujita H, Haruyama Y, Hirata K.   +6 more
europepmc   +1 more source

Marked response to memantine in refractory chronic migraine. [PDF]

Brain Circ
Nzwalo H, Ramalhete S, Freitas S.
europepmc   +1 more source